---
document_datetime: 2023-09-21 19:08:42
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kuvan-epar-all-authorised-presentations_en.pdf
document_name: kuvan-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9822046
conversion_datetime: 2025-12-30 08:59:26.885333
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|------------|--------------------------|---------------------------|-----------------------|-------------|
| EU/1/08/481/001  | Kuvan             | 100 mg     | Soluble tablet           | Oral use                  | bottle (HDPE)         | 30 tablets  |
| EU/1/08/481/002  | Kuvan             | 100 mg     | Soluble tablet           | Oral use                  | bottle (HDPE)         | 120 tablets |
| EU/1/08/481/003  | Kuvan             | 100 mg     | Soluble tablet           | Oral use                  | bottle (HDPE)         | 240 tablets |
| EU/1/08/481/004  | Kuvan             | 100 mg     | Powder for oral solution | Oral use                  | sachet (PET/alu/PE)   | 30 sachet   |
| EU/1/08/481/005  | Kuvan             | 500 mg     | Powder for oral solution | Oral use                  | sachet (PET/alu/PE)   | 30 sachet   |